ArticleCancers2021

Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation.

Francesco Buccisano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.